Hybrid AF Therapy
Persistent and Long-Standing Persistent Atrial Fibrillation
N/A (Commercial/Clinical)Active
Key Facts
Indication
Persistent and Long-Standing Persistent Atrial Fibrillation
Phase
N/A (Commercial/Clinical)
Status
Active
Company
About AtriCure
AtriCure is a commercial-stage medical device company specializing in cardiac surgical ablation and left atrial appendage exclusion for atrial fibrillation, alongside a growing cryoanalgesia platform for post-operative pain management. The company has established a significant commercial footprint with its AtriClip LAA management devices and Isolator ablation systems, supported by ongoing clinical trials like BoxX-NoAF to expand indications. Its strategic focus is on providing minimally invasive, often opioid-sparing, solutions for complex surgical needs in cardiothoracic and pain management settings.
View full company profile